Cumberland Pharmaceuticals (CPIX) Reports Q3 EPS of $0.01
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, versus $0.01 reported last year. Revenue for the quarter came in at $8.8 million, versus $7.9 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
- ASML Holdings (ASML) Reports Q4 EPS of EUR1.23
- Renasant Corp. (RNST) Misses Q4 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!